James T. Glover is SVP & Operations and CFO at ANADYS PHARMACEUTICALS INC (ANDS). They have made 7 open-market trades across 3 companies since 2006, most recently 2016-08-17.
CIK 0001231175
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
7 open-market purchases totalling $118K since 2006, never a sale. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| ONVO | BUY | 2015-08-13 | 2015-08-13 | $2.80 | $28K | -20.9% | -0.8% | -0.8% |
| VARI | BUY | 2008-07-30 | 2008-07-30 | $48.96 | $49K | N/A | N/A | N/A |
| ANDS | BUY | 2007-11-15 | 2007-11-19 | $2.06 | $4K | N/A | N/A | N/A |
| ANDS | BUY | 2007-11-08 | 2007-11-13 | $2.10 | $11K | N/A | N/A | N/A |
| ANDS | BUY | 2007-08-15 | 2007-08-16 | $2.17 | $2K | N/A | N/A | N/A |
| ANDS | BUY | 2007-02-28 | 2007-03-02 | $3.45 | $14K | N/A | N/A | N/A |
| ANDS | BUY | 2006-12-11 | 2006-12-12 | $4.60 | $10K | N/A | N/A | N/A |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.